CD286 (TLR6), Human Antibody from MILTENYI BIOTEC B.V. & Co. KG

Search, find, compare suppliers for anti-CD286 (TLR6), Human antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD286 (TLR6), Human
CloneREA382
Host SpeciesRecombinant Human
Reactive Specieshuman
IsotypeIgG1
Formatphycoerythrin (PE) conjugate
Size30 tests in 300 µL
Concentration1:11
ApplicationsFlow cytometry
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionCD286 (TLR6) Antibody, anti-human, PE, REAfinity™. Clone REA382 recognizes the human CD286 antigen, a single-pass type I membrane protein also known as toll-like receptor 6 (TLR6). CD286 is a member of the toll-like receptor family which plays a fundamental role in pathogen recognition and activation of innate immunity. Toll-like receptors are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize microbe-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various toll-like receptors exhibit different patterns of expression. CD286 is colocalized with TLR2 on the cell surface of monocytes/macrophages, dendritic cells, and granulocytes. It participates in the innate immune response to gram-positive bacteria and fungi and specifically recognizes diacylated and, to a lesser extent, triacylated lipopeptides. CD286 acts via MYD88 and TRAF6, leading to NFκB activation, cytokine secretio,n and the inflammatory response. | Additional information: Clone REA382 displays negligible binding to Fc receptors. |
Immunogenn/a
Other NamesTLR6
Gene, Accession #Gene ID: 10333
Catalog #130-106-631
Price$104
Order / More InfoCD286 (TLR6), Human Antibody from MILTENYI BIOTEC B.V. & Co. KG
Product Specific ReferencesTakeuchi, O. et al. (1999) TLR6: A novel member of an expanding toll-like receptor family. Gene 231 (1-2): 59-65. | Buwitt-Beckmann, U. et al. (2006) TLR1- and TLR6-independent recognition of bacterial lipopeptides. J. Biol. Chem. 281 (14): 9049-9057. | Jin, B. et al. (2012) The effects of TLR activation on T-cell development and differentiation. Clin. Dev. Immunol. 2012 (836485): doi: 10.1155/2012/83.
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-Straße 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197

macs@miltenyibiotec.de

https://www.miltenyibiotec.com

Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.